 John Repine
Concepts (734)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 120 | 2005 | 1125 | 4.150 |
Why?
| | Interleukin-1 | 32 | 2015 | 961 | 2.750 |
Why?
| | Xanthine Oxidase | 43 | 2003 | 79 | 2.690 |
Why?
| | Lung | 93 | 2013 | 4116 | 2.420 |
Why?
| | Oxygen | 54 | 2016 | 981 | 2.380 |
Why?
| | Hydrogen Peroxide | 49 | 2002 | 335 | 2.030 |
Why?
| | Rats | 102 | 2015 | 5585 | 1.410 |
Why?
| | Catalase | 41 | 1997 | 134 | 1.260 |
Why?
| | Oxidative Stress | 12 | 2016 | 1359 | 1.240 |
Why?
| | Antioxidants | 13 | 2012 | 550 | 1.130 |
Why?
| | Superoxides | 28 | 1999 | 198 | 1.090 |
Why?
| | Pulmonary Edema | 23 | 1997 | 105 | 1.020 |
Why?
| | Thiourea | 29 | 1995 | 41 | 1.010 |
Why?
| | Macrophages, Alveolar | 4 | 2016 | 373 | 0.990 |
Why?
| | Rats, Sprague-Dawley | 38 | 2015 | 2525 | 0.950 |
Why?
| | Endothelium, Vascular | 16 | 2002 | 956 | 0.900 |
Why?
| | Bronchoalveolar Lavage Fluid | 15 | 2016 | 638 | 0.900 |
Why?
| | Ferritins | 5 | 2004 | 70 | 0.850 |
Why?
| | Animals | 173 | 2016 | 38097 | 0.830 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2016 | 181 | 0.800 |
Why?
| | Xanthine Dehydrogenase | 14 | 1999 | 24 | 0.780 |
Why?
| | Ergothioneine | 2 | 2012 | 2 | 0.720 |
Why?
| | Lipopolysaccharides | 7 | 2015 | 858 | 0.680 |
Why?
| | Blood Bactericidal Activity | 21 | 1992 | 38 | 0.660 |
Why?
| | In Vitro Techniques | 46 | 2002 | 1049 | 0.650 |
Why?
| | Interferon Type I | 1 | 2021 | 147 | 0.620 |
Why?
| | Glutathione | 19 | 2000 | 370 | 0.610 |
Why?
| | Prostaglandins | 3 | 2019 | 94 | 0.600 |
Why?
| | Enzyme Inhibitors | 8 | 2004 | 821 | 0.590 |
Why?
| | Ischemia | 11 | 1997 | 422 | 0.590 |
Why?
| | Reperfusion Injury | 15 | 1997 | 292 | 0.590 |
Why?
| | Persian Gulf Syndrome | 1 | 2019 | 18 | 0.590 |
Why?
| | Chemokines, CXC | 6 | 2005 | 68 | 0.580 |
Why?
| | Leukotrienes | 1 | 2019 | 28 | 0.580 |
Why?
| | Free Radicals | 24 | 2008 | 105 | 0.580 |
Why?
| | Pneumonia | 6 | 2011 | 636 | 0.570 |
Why?
| | Pulmonary Alveoli | 23 | 2011 | 387 | 0.570 |
Why?
| | Aerosols | 4 | 2016 | 145 | 0.570 |
Why?
| | Capillary Permeability | 14 | 2002 | 132 | 0.570 |
Why?
| | Virus Diseases | 1 | 2021 | 216 | 0.560 |
Why?
| | Dimethyl Sulfoxide | 18 | 1994 | 42 | 0.560 |
Why?
| | Superoxide Dismutase | 27 | 1996 | 308 | 0.550 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 920 | 0.550 |
Why?
| | Rats, Inbred Strains | 37 | 1992 | 321 | 0.530 |
Why?
| | Chemotactic Factors | 11 | 1997 | 43 | 0.520 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 269 | 0.520 |
Why?
| | Intercellular Signaling Peptides and Proteins | 6 | 2005 | 376 | 0.520 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 372 | 0.520 |
Why?
| | Cytokines | 8 | 2014 | 2069 | 0.510 |
Why?
| | Lung Injury | 9 | 2014 | 249 | 0.510 |
Why?
| | Oxidants | 6 | 2004 | 99 | 0.510 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 396 | 0.490 |
Why?
| | Chemotaxis, Leukocyte | 10 | 1997 | 114 | 0.490 |
Why?
| | Malathion | 1 | 2016 | 3 | 0.480 |
Why?
| | Staphylococcus aureus | 29 | 1988 | 453 | 0.470 |
Why?
| | Tetradecanoylphorbol Acetate | 20 | 1994 | 149 | 0.460 |
Why?
| | Leukocyte Elastase | 5 | 2002 | 75 | 0.450 |
Why?
| | Platelet Activating Factor | 4 | 2002 | 45 | 0.440 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 66 | 0.440 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 76 | 0.440 |
Why?
| | Capillaries | 2 | 2015 | 125 | 0.440 |
Why?
| | Glutamine | 1 | 2015 | 109 | 0.430 |
Why?
| | Myocardial Reperfusion Injury | 9 | 1992 | 139 | 0.430 |
Why?
| | Macrophages | 24 | 1991 | 1507 | 0.420 |
Why?
| | Kidney | 11 | 1999 | 1496 | 0.420 |
Why?
| | Phagocytosis | 22 | 2007 | 296 | 0.410 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2015 | 288 | 0.410 |
Why?
| | Respiration, Artificial | 3 | 2015 | 714 | 0.400 |
Why?
| | Lung Diseases | 10 | 2007 | 782 | 0.400 |
Why?
| | Prostaglandin D2 | 1 | 2013 | 21 | 0.400 |
Why?
| | Quinacrine | 3 | 2004 | 9 | 0.390 |
Why?
| | Peroxidase | 15 | 2003 | 168 | 0.390 |
Why?
| | Nitric Oxide | 8 | 2014 | 892 | 0.390 |
Why?
| | Hydroxides | 9 | 1991 | 27 | 0.390 |
Why?
| | Neutrophil Infiltration | 1 | 2013 | 107 | 0.390 |
Why?
| | Perfusion | 22 | 2002 | 251 | 0.380 |
Why?
| | Hemorrhage | 4 | 2004 | 822 | 0.370 |
Why?
| | L-Lactate Dehydrogenase | 17 | 2013 | 112 | 0.370 |
Why?
| | Allopurinol | 11 | 2003 | 70 | 0.360 |
Why?
| | Male | 102 | 2019 | 73003 | 0.360 |
Why?
| | Myocardium | 14 | 1992 | 935 | 0.360 |
Why?
| | Antigens, CD | 1 | 2015 | 558 | 0.350 |
Why?
| | Pulmonary Artery | 13 | 1997 | 1129 | 0.350 |
Why?
| | Cell Adhesion | 15 | 2007 | 451 | 0.340 |
Why?
| | Serine Proteinase Inhibitors | 4 | 2002 | 48 | 0.340 |
Why?
| | Fruit | 1 | 2012 | 146 | 0.340 |
Why?
| | Rabbits | 29 | 1991 | 653 | 0.330 |
Why?
| | Aldehyde Oxidoreductases | 4 | 1999 | 28 | 0.330 |
Why?
| | Vegetables | 1 | 2012 | 162 | 0.330 |
Why?
| | Inflammation | 6 | 2016 | 2883 | 0.330 |
Why?
| | Tumor Necrosis Factor-alpha | 8 | 2005 | 1217 | 0.330 |
Why?
| | Pancreatic Elastase | 8 | 1993 | 53 | 0.330 |
Why?
| | Cells, Cultured | 28 | 2008 | 4151 | 0.330 |
Why?
| | Tungsten | 15 | 2003 | 30 | 0.320 |
Why?
| | Pentoxifylline | 4 | 1997 | 23 | 0.320 |
Why?
| | Pulmonary Circulation | 6 | 2005 | 430 | 0.320 |
Why?
| | Reactive Oxygen Species | 5 | 1999 | 611 | 0.310 |
Why?
| | Cattle | 18 | 2007 | 946 | 0.310 |
Why?
| | Heart | 10 | 1994 | 626 | 0.300 |
Why?
| | Burns | 4 | 2019 | 374 | 0.300 |
Why?
| | Humans | 125 | 2021 | 145763 | 0.300 |
Why?
| | Oxidation-Reduction | 22 | 1999 | 1068 | 0.290 |
Why?
| | Erythrocytes | 11 | 1995 | 749 | 0.280 |
Why?
| | Deferoxamine | 3 | 2002 | 27 | 0.280 |
Why?
| | Soot | 1 | 2008 | 23 | 0.280 |
Why?
| | Phorbols | 8 | 1986 | 10 | 0.280 |
Why?
| | Vitamin E | 4 | 1998 | 125 | 0.280 |
Why?
| | Tissue Plasminogen Activator | 3 | 2005 | 248 | 0.280 |
Why?
| | Gulf War | 2 | 2019 | 15 | 0.270 |
Why?
| | Granulomatous Disease, Chronic | 12 | 1988 | 49 | 0.270 |
Why?
| | Oxygen Consumption | 19 | 1995 | 719 | 0.270 |
Why?
| | Biomarkers | 9 | 2019 | 4302 | 0.270 |
Why?
| | Receptors, Interleukin-1 | 4 | 1997 | 211 | 0.270 |
Why?
| | Dietary Supplements | 1 | 2012 | 584 | 0.260 |
Why?
| | Dinoprost | 2 | 2019 | 51 | 0.260 |
Why?
| | Tyrosine | 2 | 2008 | 217 | 0.250 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2007 | 132 | 0.250 |
Why?
| | Bacterial Infections | 7 | 1993 | 246 | 0.250 |
Why?
| | Phosphatidic Acids | 2 | 1997 | 8 | 0.240 |
Why?
| | Free Radical Scavengers | 8 | 2000 | 82 | 0.240 |
Why?
| | Blood Platelets | 7 | 1992 | 379 | 0.240 |
Why?
| | Endothelium | 10 | 1997 | 119 | 0.230 |
Why?
| | Leukocytes | 7 | 2007 | 296 | 0.230 |
Why?
| | Shock, Septic | 3 | 2000 | 227 | 0.230 |
Why?
| | Trachea | 6 | 2005 | 258 | 0.230 |
Why?
| | Phagocytes | 2 | 2003 | 80 | 0.230 |
Why?
| | Particulate Matter | 1 | 2008 | 326 | 0.230 |
Why?
| | Muscles | 3 | 1991 | 330 | 0.230 |
Why?
| | Administration, Inhalation | 5 | 2016 | 571 | 0.220 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 32 | 0.220 |
Why?
| | Recombinant Proteins | 10 | 2005 | 1368 | 0.220 |
Why?
| | Leukotriene B4 | 3 | 2016 | 36 | 0.220 |
Why?
| | Krypton | 3 | 2011 | 4 | 0.220 |
Why?
| | Endotoxins | 7 | 1992 | 217 | 0.210 |
Why?
| | Obesity | 2 | 2015 | 3118 | 0.210 |
Why?
| | Tidal Volume | 2 | 2015 | 109 | 0.210 |
Why?
| | Growth Substances | 4 | 1997 | 138 | 0.200 |
Why?
| | Coronary Disease | 5 | 1991 | 382 | 0.200 |
Why?
| | Glutathione Peroxidase | 10 | 1994 | 41 | 0.200 |
Why?
| | Leukocyte Count | 8 | 2003 | 318 | 0.200 |
Why?
| | Skin | 3 | 1995 | 754 | 0.200 |
Why?
| | Nitroblue Tetrazolium | 8 | 2000 | 12 | 0.200 |
Why?
| | Mitochondria | 5 | 2008 | 992 | 0.190 |
Why?
| | Smoking | 7 | 2014 | 1477 | 0.190 |
Why?
| | Intercellular Junctions | 1 | 2002 | 35 | 0.190 |
Why?
| | Acute Kidney Injury | 3 | 1997 | 874 | 0.190 |
Why?
| | Cell Count | 4 | 2013 | 319 | 0.190 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2003 | 62 | 0.190 |
Why?
| | Iron Chelating Agents | 1 | 2002 | 17 | 0.180 |
Why?
| | Permeability | 7 | 2002 | 169 | 0.180 |
Why?
| | Organ Size | 10 | 1998 | 461 | 0.180 |
Why?
| | Postoperative Complications | 1 | 2015 | 2977 | 0.180 |
Why?
| | Amitrole | 8 | 1990 | 9 | 0.180 |
Why?
| | Iron | 8 | 2002 | 359 | 0.180 |
Why?
| | Environmental Exposure | 2 | 2017 | 578 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 2028 | 0.180 |
Why?
| | Edema | 4 | 1997 | 125 | 0.180 |
Why?
| | Particle Size | 3 | 2016 | 381 | 0.170 |
Why?
| | Neutropenia | 5 | 1997 | 154 | 0.170 |
Why?
| | Thromboxanes | 4 | 1988 | 14 | 0.170 |
Why?
| | von Willebrand Factor | 3 | 2019 | 85 | 0.170 |
Why?
| | Corneal Stroma | 1 | 2001 | 24 | 0.170 |
Why?
| | Administration, Intranasal | 1 | 2021 | 94 | 0.170 |
Why?
| | Photorefractive Keratectomy | 1 | 2001 | 21 | 0.170 |
Why?
| | Glycine | 1 | 2002 | 186 | 0.160 |
Why?
| | Sodium | 2 | 1999 | 198 | 0.160 |
Why?
| | Air Pollutants, Occupational | 1 | 2001 | 41 | 0.160 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 474 | 0.160 |
Why?
| | Risk Factors | 9 | 2019 | 10917 | 0.160 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 1997 | 28 | 0.160 |
Why?
| | Intubation, Intratracheal | 6 | 2002 | 327 | 0.160 |
Why?
| | Renal Circulation | 4 | 1997 | 75 | 0.160 |
Why?
| | Indicators and Reagents | 6 | 2000 | 106 | 0.150 |
Why?
| | Phagocyte Bactericidal Dysfunction | 5 | 1979 | 11 | 0.150 |
Why?
| | Acute Disease | 8 | 1999 | 1036 | 0.150 |
Why?
| | Nitrates | 2 | 2017 | 96 | 0.150 |
Why?
| | Kinetics | 12 | 1996 | 1568 | 0.150 |
Why?
| | Sialoglycoproteins | 2 | 1997 | 157 | 0.150 |
Why?
| | Saccharomyces cerevisiae | 3 | 1995 | 574 | 0.150 |
Why?
| | Chemokine CXCL1 | 4 | 2005 | 76 | 0.150 |
Why?
| | Alcohol Dehydrogenase | 1 | 1999 | 16 | 0.150 |
Why?
| | Physical Exertion | 1 | 2000 | 205 | 0.150 |
Why?
| | Lactoferrin | 2 | 2017 | 36 | 0.140 |
Why?
| | Luminescent Measurements | 8 | 1997 | 75 | 0.140 |
Why?
| | Triazoles | 3 | 2002 | 191 | 0.140 |
Why?
| | Interleukin-8 | 3 | 1997 | 269 | 0.140 |
Why?
| | Monocytes | 7 | 2007 | 539 | 0.140 |
Why?
| | Brain Edema | 2 | 1990 | 62 | 0.140 |
Why?
| | Kidney Tubules, Proximal | 1 | 1999 | 129 | 0.140 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 231 | 0.140 |
Why?
| | Alprostadil | 2 | 1997 | 29 | 0.140 |
Why?
| | Sulfonamides | 1 | 2002 | 583 | 0.130 |
Why?
| | Female | 32 | 2019 | 79035 | 0.130 |
Why?
| | Multiple Trauma | 1 | 1999 | 121 | 0.130 |
Why?
| | Acetylcysteine | 3 | 1995 | 139 | 0.130 |
Why?
| | Molybdenum | 1 | 1997 | 6 | 0.130 |
Why?
| | Veterans Health | 1 | 2019 | 190 | 0.130 |
Why?
| | Lung Diseases, Obstructive | 1 | 1997 | 43 | 0.130 |
Why?
| | Phospholipases A | 1 | 1997 | 97 | 0.120 |
Why?
| | Chronic Disease | 3 | 2014 | 1812 | 0.120 |
Why?
| | Therapeutic Irrigation | 7 | 1997 | 68 | 0.120 |
Why?
| | Polyethylene Glycols | 5 | 1990 | 649 | 0.120 |
Why?
| | Neutrophil Activation | 1 | 1997 | 84 | 0.120 |
Why?
| | Chromatography, Affinity | 1 | 1996 | 80 | 0.120 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 627 | 0.120 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1996 | 162 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1996 | 96 | 0.120 |
Why?
| | DNA Damage | 1 | 1999 | 437 | 0.120 |
Why?
| | Sepsis | 2 | 2000 | 664 | 0.110 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1996 | 154 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 849 | 0.110 |
Why?
| | One-Lung Ventilation | 1 | 2015 | 6 | 0.110 |
Why?
| | Menstruation | 2 | 1986 | 40 | 0.110 |
Why?
| | Carbonates | 1 | 1995 | 13 | 0.110 |
Why?
| | Mice, Inbred Strains | 1 | 2016 | 396 | 0.110 |
Why?
| | Pulmonary Surfactants | 3 | 2007 | 105 | 0.110 |
Why?
| | Adjuvants, Immunologic | 1 | 1997 | 244 | 0.110 |
Why?
| | Ethanol | 2 | 1999 | 631 | 0.110 |
Why?
| | Vitamin E Deficiency | 1 | 1995 | 43 | 0.110 |
Why?
| | Interleukin-10 | 1 | 1997 | 310 | 0.110 |
Why?
| | Sodium Bicarbonate | 1 | 1995 | 48 | 0.110 |
Why?
| | Serum Albumin | 4 | 1994 | 147 | 0.110 |
Why?
| | Hypoxia | 3 | 2015 | 1199 | 0.110 |
Why?
| | Vinblastine | 6 | 1997 | 75 | 0.110 |
Why?
| | Muscle, Smooth, Vascular | 2 | 1997 | 450 | 0.110 |
Why?
| | Predictive Value of Tests | 5 | 2019 | 2123 | 0.110 |
Why?
| | Glutathione Disulfide | 5 | 1994 | 30 | 0.110 |
Why?
| | Carbon Dioxide | 2 | 1995 | 227 | 0.110 |
Why?
| | Oligonucleotides | 1 | 1995 | 153 | 0.110 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1994 | 37 | 0.110 |
Why?
| | Vasoconstriction | 3 | 1988 | 216 | 0.100 |
Why?
| | Reperfusion | 2 | 1992 | 54 | 0.100 |
Why?
| | Cell Movement | 6 | 1996 | 961 | 0.100 |
Why?
| | Positive-Pressure Respiration | 1 | 2015 | 115 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2019 | 3634 | 0.100 |
Why?
| | Insufflation | 1 | 2013 | 14 | 0.100 |
Why?
| | Granulocytes | 3 | 1982 | 82 | 0.100 |
Why?
| | Critical Care | 1 | 2000 | 702 | 0.100 |
Why?
| | Liver | 2 | 2000 | 1899 | 0.100 |
Why?
| | Oligopeptides | 2 | 1992 | 267 | 0.100 |
Why?
| | Molecular Sequence Data | 6 | 1999 | 2883 | 0.100 |
Why?
| | Liposomes | 3 | 1997 | 263 | 0.100 |
Why?
| | Smoke | 2 | 2007 | 148 | 0.100 |
Why?
| | Hemolysis | 2 | 1993 | 242 | 0.100 |
Why?
| | Purines | 4 | 2002 | 187 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2933 | 0.090 |
Why?
| | Hydroxyl Radical | 7 | 1991 | 86 | 0.090 |
Why?
| | Hypertension, Pulmonary | 5 | 1987 | 1957 | 0.090 |
Why?
| | Sulfhydryl Compounds | 3 | 1992 | 189 | 0.090 |
Why?
| | Perioperative Care | 1 | 2015 | 231 | 0.090 |
Why?
| | Serpins | 1 | 1992 | 28 | 0.090 |
Why?
| | Glucose Oxidase | 3 | 1987 | 25 | 0.090 |
Why?
| | Microscopy, Electron | 6 | 2000 | 414 | 0.090 |
Why?
| | Pleural Effusion | 4 | 1992 | 59 | 0.090 |
Why?
| | Tetrazolium Salts | 5 | 1991 | 18 | 0.090 |
Why?
| | Opsonin Proteins | 7 | 1988 | 19 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 344 | 0.090 |
Why?
| | Acute Lung Injury | 1 | 2015 | 307 | 0.090 |
Why?
| | Respiration | 3 | 2001 | 207 | 0.090 |
Why?
| | Escherichia coli | 4 | 1988 | 835 | 0.090 |
Why?
| | Complement C2 | 4 | 1979 | 8 | 0.090 |
Why?
| | Inhalation | 1 | 2011 | 29 | 0.080 |
Why?
| | Melanocytes | 1 | 1991 | 65 | 0.080 |
Why?
| | Cell Hypoxia | 1 | 1992 | 247 | 0.080 |
Why?
| | Oxidoreductases | 1 | 1991 | 91 | 0.080 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 1997 | 38 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 2 | 1991 | 574 | 0.080 |
Why?
| | Muramidase | 3 | 1988 | 67 | 0.080 |
Why?
| | Azepines | 2 | 2002 | 105 | 0.080 |
Why?
| | Phosphorylation | 1 | 2015 | 1708 | 0.080 |
Why?
| | Salmonella typhimurium | 2 | 1991 | 188 | 0.080 |
Why?
| | Electron Spin Resonance Spectroscopy | 2 | 2008 | 94 | 0.080 |
Why?
| | Base Sequence | 5 | 1999 | 2171 | 0.080 |
Why?
| | Xenon Isotopes | 2 | 2007 | 7 | 0.080 |
Why?
| | Brain | 3 | 1992 | 2969 | 0.080 |
Why?
| | Diterpenes | 3 | 1975 | 26 | 0.080 |
Why?
| | Shock | 1 | 1991 | 110 | 0.080 |
Why?
| | Paraquat | 1 | 1990 | 13 | 0.080 |
Why?
| | Riboflavin | 1 | 1990 | 15 | 0.080 |
Why?
| | Keratinocytes | 1 | 1991 | 249 | 0.080 |
Why?
| | Glycoconjugates | 1 | 1990 | 7 | 0.080 |
Why?
| | Blood Cells | 1 | 1990 | 38 | 0.080 |
Why?
| | Adult | 22 | 2019 | 40872 | 0.080 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1101 | 0.080 |
Why?
| | Middle Aged | 10 | 2019 | 36302 | 0.080 |
Why?
| | Arachidonic Acids | 1 | 1990 | 42 | 0.080 |
Why?
| | Factor VII | 1 | 1989 | 24 | 0.080 |
Why?
| | Fibroblasts | 3 | 1991 | 1027 | 0.070 |
Why?
| | Hyperbaric Oxygenation | 2 | 1987 | 39 | 0.070 |
Why?
| | Reference Values | 4 | 1997 | 798 | 0.070 |
Why?
| | Aldehyde Oxidase | 3 | 1999 | 3 | 0.070 |
Why?
| | Substrate Specificity | 3 | 1996 | 387 | 0.070 |
Why?
| | Intestines | 1 | 1992 | 354 | 0.070 |
Why?
| | Alkaline Phosphatase | 3 | 1986 | 144 | 0.070 |
Why?
| | RNA | 1 | 1995 | 912 | 0.070 |
Why?
| | Mycobacterium bovis | 3 | 1985 | 15 | 0.070 |
Why?
| | Biological Factors | 1 | 1989 | 39 | 0.070 |
Why?
| | Metals | 1 | 1990 | 136 | 0.070 |
Why?
| | Krypton Radioisotopes | 1 | 2008 | 1 | 0.070 |
Why?
| | Myocardial Reperfusion | 4 | 1994 | 56 | 0.070 |
Why?
| | Superantigens | 1 | 1988 | 70 | 0.070 |
Why?
| | Enterotoxins | 1 | 1988 | 89 | 0.070 |
Why?
| | Antigens | 2 | 1989 | 348 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 1999 | 2131 | 0.070 |
Why?
| | Thromboxane B2 | 2 | 1988 | 23 | 0.070 |
Why?
| | Time Factors | 10 | 2000 | 7133 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2005 | 2805 | 0.070 |
Why?
| | Blood Pressure | 6 | 1995 | 1782 | 0.070 |
Why?
| | Nitroarginine | 2 | 1999 | 57 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 1988 | 108 | 0.070 |
Why?
| | Nitroprusside | 2 | 1999 | 71 | 0.070 |
Why?
| | Mice | 5 | 2016 | 18355 | 0.070 |
Why?
| | Proteins | 5 | 1997 | 1023 | 0.070 |
Why?
| | Exercise | 1 | 2000 | 2205 | 0.070 |
Why?
| | Inhalation Exposure | 1 | 2008 | 103 | 0.070 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 27 | 0.070 |
Why?
| | Integrin alpha4beta1 | 1 | 2007 | 8 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 2 | 1998 | 89 | 0.070 |
Why?
| | Epithelial Cells | 2 | 2007 | 1134 | 0.060 |
Why?
| | Glomerular Filtration Rate | 4 | 1997 | 765 | 0.060 |
Why?
| | Creatine Kinase | 3 | 2000 | 72 | 0.060 |
Why?
| | Image Enhancement | 1 | 2008 | 200 | 0.060 |
Why?
| | Phospholipids | 2 | 2000 | 214 | 0.060 |
Why?
| | Zymosan | 5 | 1990 | 39 | 0.060 |
Why?
| | Nylons | 3 | 1984 | 24 | 0.060 |
Why?
| | Disease | 2 | 2017 | 96 | 0.060 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 1994 | 70 | 0.060 |
Why?
| | Alcoholism | 1 | 2014 | 826 | 0.060 |
Why?
| | Cell Separation | 2 | 1997 | 306 | 0.060 |
Why?
| | Thromboxane A2 | 2 | 1983 | 9 | 0.060 |
Why?
| | Complement Activation | 3 | 1995 | 399 | 0.060 |
Why?
| | Ischemic Attack, Transient | 1 | 1987 | 71 | 0.060 |
Why?
| | Cell Division | 2 | 1985 | 757 | 0.060 |
Why?
| | DNA, Complementary | 2 | 1999 | 273 | 0.060 |
Why?
| | Arginine | 2 | 1998 | 264 | 0.060 |
Why?
| | NF-kappa B | 2 | 2002 | 667 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2393 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 2 | 1999 | 387 | 0.060 |
Why?
| | Cytochrome c Group | 3 | 1994 | 43 | 0.060 |
Why?
| | Polymerase Chain Reaction | 3 | 1999 | 1043 | 0.060 |
Why?
| | Menstrual Cycle | 1 | 1986 | 145 | 0.060 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 1985 | 56 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1999 | 538 | 0.060 |
Why?
| | HEPES | 1 | 1985 | 2 | 0.060 |
Why?
| | Contrast Media | 1 | 2008 | 497 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3915 | 0.060 |
Why?
| | Glycoproteins | 1 | 1987 | 354 | 0.060 |
Why?
| | Agranulocytosis | 2 | 1982 | 30 | 0.050 |
Why?
| | Staphylococcal Infections | 2 | 1986 | 393 | 0.050 |
Why?
| | Drug Carriers | 2 | 1997 | 136 | 0.050 |
Why?
| | Isotopes | 3 | 2011 | 33 | 0.050 |
Why?
| | Models, Biological | 4 | 2011 | 1764 | 0.050 |
Why?
| | Peroxidases | 2 | 1991 | 28 | 0.050 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 1997 | 253 | 0.050 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2017 | 81 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 1987 | 290 | 0.050 |
Why?
| | Mesocricetus | 2 | 1995 | 52 | 0.050 |
Why?
| | Mannitol | 4 | 1991 | 40 | 0.050 |
Why?
| | Enzyme Induction | 1 | 2003 | 88 | 0.050 |
Why?
| | Tuberculoma | 1 | 1983 | 2 | 0.050 |
Why?
| | Iron, Dietary | 1 | 2003 | 23 | 0.050 |
Why?
| | Kidney Diseases | 1 | 1987 | 426 | 0.050 |
Why?
| | Cricetinae | 2 | 1995 | 305 | 0.050 |
Why?
| | Aspirin | 2 | 1984 | 406 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2005 | 316 | 0.050 |
Why?
| | Vasodilator Agents | 2 | 1999 | 330 | 0.050 |
Why?
| | Lidocaine | 3 | 1987 | 55 | 0.050 |
Why?
| | Osmolar Concentration | 3 | 1994 | 168 | 0.050 |
Why?
| | Methylprednisolone | 1 | 1983 | 59 | 0.050 |
Why?
| | Carrier Proteins | 2 | 1997 | 729 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2002 | 29 | 0.050 |
Why?
| | Tetracaine | 2 | 1979 | 6 | 0.050 |
Why?
| | Hematocrit | 3 | 1992 | 108 | 0.050 |
Why?
| | Blastomycosis | 2 | 1981 | 11 | 0.050 |
Why?
| | Cryptococcus neoformans | 1 | 1982 | 21 | 0.050 |
Why?
| | Piperazines | 1 | 1985 | 375 | 0.050 |
Why?
| | Leukemia, Myeloid | 2 | 1979 | 48 | 0.050 |
Why?
| | Cryptococcus | 1 | 1982 | 16 | 0.040 |
Why?
| | Chediak-Higashi Syndrome | 2 | 1979 | 7 | 0.040 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1983 | 127 | 0.040 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 1982 | 6 | 0.040 |
Why?
| | Pyelonephritis | 1 | 1982 | 13 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2005 | 381 | 0.040 |
Why?
| | Chromatography, Gas | 3 | 1988 | 30 | 0.040 |
Why?
| | Nitrogen Mustard Compounds | 1 | 1981 | 9 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 3 | 1995 | 532 | 0.040 |
Why?
| | Disease Models, Animal | 3 | 1998 | 4568 | 0.040 |
Why?
| | Environmental Pollution | 1 | 2001 | 21 | 0.040 |
Why?
| | Complement Pathway, Alternative | 1 | 1982 | 121 | 0.040 |
Why?
| | Volatilization | 1 | 2001 | 45 | 0.040 |
Why?
| | Signal Transduction | 1 | 1995 | 5223 | 0.040 |
Why?
| | DNA, Superhelical | 1 | 1981 | 12 | 0.040 |
Why?
| | Lasers, Excimer | 1 | 2001 | 30 | 0.040 |
Why?
| | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1992 | 6 | 0.040 |
Why?
| | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1992 | 9 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 4 | 1990 | 196 | 0.040 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2000 | 31 | 0.040 |
Why?
| | Malondialdehyde | 1 | 2000 | 31 | 0.040 |
Why?
| | Mycoses | 1 | 1981 | 88 | 0.040 |
Why?
| | DNA Primers | 2 | 1999 | 505 | 0.040 |
Why?
| | Urea | 3 | 1990 | 85 | 0.040 |
Why?
| | Glucose | 8 | 1980 | 1048 | 0.040 |
Why?
| | Prospective Studies | 3 | 2019 | 8075 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 1997 | 2000 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2000 | 85 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2003 | 784 | 0.040 |
Why?
| | Methylurea Compounds | 2 | 1994 | 7 | 0.040 |
Why?
| | Ethylenes | 1 | 1979 | 16 | 0.040 |
Why?
| | 6-Aminonicotinamide | 2 | 1990 | 2 | 0.040 |
Why?
| | Glutathione Reductase | 2 | 1990 | 24 | 0.040 |
Why?
| | DNA, Single-Stranded | 1 | 1981 | 117 | 0.040 |
Why?
| | Chemical Phenomena | 2 | 1995 | 77 | 0.040 |
Why?
| | Organ Preservation | 2 | 1991 | 125 | 0.040 |
Why?
| | Coronary Circulation | 3 | 1991 | 134 | 0.040 |
Why?
| | Premedication | 3 | 1985 | 45 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 424 | 0.040 |
Why?
| | Chemotaxis | 2 | 1979 | 122 | 0.040 |
Why?
| | Radioimmunoassay | 2 | 1997 | 165 | 0.040 |
Why?
| | Bradykinin | 1 | 1999 | 49 | 0.040 |
Why?
| | Hot Temperature | 3 | 1994 | 396 | 0.040 |
Why?
| | Cyclic GMP | 1 | 1999 | 90 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 1997 | 507 | 0.040 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1999 | 55 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2000 | 450 | 0.040 |
Why?
| | DNA, Viral | 1 | 1981 | 356 | 0.040 |
Why?
| | Albumins | 3 | 1991 | 119 | 0.040 |
Why?
| | Myocardial Contraction | 3 | 1989 | 293 | 0.040 |
Why?
| | Instillation, Drug | 1 | 1998 | 9 | 0.040 |
Why?
| | Culture Techniques | 2 | 1992 | 66 | 0.030 |
Why?
| | Gerbillinae | 2 | 1990 | 72 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 1998 | 116 | 0.030 |
Why?
| | Coculture Techniques | 1 | 1999 | 247 | 0.030 |
Why?
| | Acetylcholine | 1 | 1999 | 209 | 0.030 |
Why?
| | Anesthetics, Local | 1 | 1979 | 104 | 0.030 |
Why?
| | Hyperoxia | 1 | 1999 | 107 | 0.030 |
Why?
| | Pulmonary Ventilation | 2 | 2011 | 82 | 0.030 |
Why?
| | Myocardial Infarction | 3 | 1991 | 1211 | 0.030 |
Why?
| | Levamisole | 1 | 1977 | 22 | 0.030 |
Why?
| | Cloning, Organism | 1 | 1997 | 7 | 0.030 |
Why?
| | Linoleic Acid | 1 | 1997 | 44 | 0.030 |
Why?
| | Oleic Acid | 1 | 1997 | 40 | 0.030 |
Why?
| | Muscle Contraction | 2 | 1990 | 429 | 0.030 |
Why?
| | Phospholipases A2 | 1 | 1997 | 79 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2017 | 165 | 0.030 |
Why?
| | Methane | 3 | 1983 | 45 | 0.030 |
Why?
| | Electron Transport | 2 | 1995 | 110 | 0.030 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1997 | 24 | 0.030 |
Why?
| | NADP | 2 | 1988 | 52 | 0.030 |
Why?
| | Absorption | 1 | 1997 | 60 | 0.030 |
Why?
| | Tumor Necrosis Factor Decoy Receptors | 1 | 1996 | 8 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1990 | 592 | 0.030 |
Why?
| | Complement System Proteins | 2 | 1977 | 314 | 0.030 |
Why?
| | Injury Severity Score | 1 | 1999 | 599 | 0.030 |
Why?
| | Benzamidines | 1 | 1996 | 3 | 0.030 |
Why?
| | Isoelectric Point | 1 | 1996 | 22 | 0.030 |
Why?
| | Xanthines | 1 | 1996 | 23 | 0.030 |
Why?
| | Blood Proteins | 1 | 1978 | 239 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 1996 | 80 | 0.030 |
Why?
| | Immunoassay | 1 | 1997 | 109 | 0.030 |
Why?
| | Hydrolysis | 1 | 1997 | 197 | 0.030 |
Why?
| | Sepharose | 1 | 1996 | 32 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 1998 | 782 | 0.030 |
Why?
| | Sodium Chloride | 2 | 1990 | 138 | 0.030 |
Why?
| | Interleukin-4 | 1 | 1997 | 207 | 0.030 |
Why?
| | Endocarditis, Bacterial | 1 | 1976 | 46 | 0.030 |
Why?
| | HIV Infections | 1 | 1992 | 3195 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2001 | 610 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1505 | 0.030 |
Why?
| | Chemistry, Physical | 1 | 1995 | 37 | 0.030 |
Why?
| | Cathepsin G | 1 | 1995 | 4 | 0.030 |
Why?
| | Diet | 4 | 1995 | 1278 | 0.030 |
Why?
| | Cathepsins | 1 | 1995 | 24 | 0.030 |
Why?
| | Injections | 1 | 1996 | 199 | 0.030 |
Why?
| | Adenine | 2 | 1997 | 339 | 0.030 |
Why?
| | Hydrochloric Acid | 1 | 1995 | 9 | 0.030 |
Why?
| | Isoenzymes | 1 | 1996 | 295 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2003 | 2050 | 0.030 |
Why?
| | Aged | 5 | 2019 | 26215 | 0.030 |
Why?
| | Cross Reactions | 1 | 1995 | 130 | 0.030 |
Why?
| | Sex Chromosomes | 1 | 1975 | 58 | 0.030 |
Why?
| | Single-Blind Method | 1 | 1996 | 318 | 0.030 |
Why?
| | Injections, Spinal | 1 | 1995 | 120 | 0.030 |
Why?
| | Erythrocyte Indices | 1 | 1995 | 33 | 0.030 |
Why?
| | Factor VIII | 2 | 1993 | 106 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1995 | 129 | 0.030 |
Why?
| | Apoptosis | 1 | 2003 | 2443 | 0.030 |
Why?
| | Chlorobenzenes | 1 | 1994 | 18 | 0.030 |
Why?
| | Tuberculosis, Pleural | 2 | 1985 | 7 | 0.030 |
Why?
| | ROC Curve | 1 | 1997 | 618 | 0.030 |
Why?
| | Cytosol | 1 | 1995 | 213 | 0.030 |
Why?
| | Uteroglobin | 1 | 2014 | 31 | 0.030 |
Why?
| | Acyltransferases | 1 | 1995 | 78 | 0.030 |
Why?
| | Leukotriene Antagonists | 1 | 1994 | 24 | 0.030 |
Why?
| | Croton Oil | 1 | 1974 | 3 | 0.030 |
Why?
| | Hydroxyurea | 1 | 1994 | 34 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1994 | 34 | 0.030 |
Why?
| | Enzyme Activation | 3 | 1991 | 762 | 0.030 |
Why?
| | Drug Tolerance | 1 | 1994 | 99 | 0.030 |
Why?
| | Ficoll | 1 | 1994 | 4 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 1997 | 423 | 0.030 |
Why?
| | Nitrites | 1 | 2014 | 88 | 0.030 |
Why?
| | Adolescent | 8 | 1999 | 22573 | 0.030 |
Why?
| | Anions | 3 | 1995 | 29 | 0.030 |
Why?
| | Serum Albumin, Radio-Iodinated | 1 | 1994 | 2 | 0.030 |
Why?
| | Methods | 2 | 1984 | 68 | 0.030 |
Why?
| | Breath Tests | 1 | 1994 | 77 | 0.030 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 1995 | 96 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 81 | 0.030 |
Why?
| | Drug Combinations | 1 | 1995 | 396 | 0.030 |
Why?
| | United States | 1 | 2011 | 16123 | 0.030 |
Why?
| | Pressure | 2 | 1986 | 226 | 0.030 |
Why?
| | Dogs | 6 | 1991 | 478 | 0.020 |
Why?
| | Diptera | 1 | 1993 | 30 | 0.020 |
Why?
| | Stomach | 1 | 1994 | 111 | 0.020 |
Why?
| | Genes | 1 | 1993 | 228 | 0.020 |
Why?
| | Clinical Enzyme Tests | 1 | 1993 | 9 | 0.020 |
Why?
| | Haploidy | 1 | 1993 | 28 | 0.020 |
Why?
| | Sequence Alignment | 1 | 1993 | 362 | 0.020 |
Why?
| | Epoprostenol | 2 | 1991 | 132 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 1994 | 285 | 0.020 |
Why?
| | Platelet Count | 2 | 1984 | 94 | 0.020 |
Why?
| | Shock, Hemorrhagic | 1 | 1995 | 199 | 0.020 |
Why?
| | Hemoglobins | 1 | 1995 | 386 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 1992 | 197 | 0.020 |
Why?
| | Chromium | 1 | 1992 | 18 | 0.020 |
Why?
| | Drosophila | 1 | 1993 | 166 | 0.020 |
Why?
| | Gene Expression | 2 | 1995 | 1478 | 0.020 |
Why?
| | Glucosephosphates | 1 | 1991 | 3 | 0.020 |
Why?
| | Glucose-6-Phosphate | 1 | 1991 | 6 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1978 | 1166 | 0.020 |
Why?
| | Elapid Venoms | 1 | 1991 | 13 | 0.020 |
Why?
| | Mechlorethamine | 2 | 1982 | 52 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 1987 | 860 | 0.020 |
Why?
| | Survival Rate | 1 | 1997 | 2094 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3416 | 0.020 |
Why?
| | Ethylmaleimide | 2 | 1989 | 18 | 0.020 |
Why?
| | Disease Progression | 1 | 1999 | 2865 | 0.020 |
Why?
| | Double-Blind Method | 1 | 1996 | 2064 | 0.020 |
Why?
| | Pentetic Acid | 1 | 1991 | 13 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 1995 | 892 | 0.020 |
Why?
| | Ventricular Function | 1 | 1991 | 53 | 0.020 |
Why?
| | Sodium Azide | 1 | 1990 | 5 | 0.020 |
Why?
| | Formaldehyde | 1 | 1991 | 65 | 0.020 |
Why?
| | Alcohols | 3 | 1975 | 26 | 0.020 |
Why?
| | Azides | 1 | 1990 | 49 | 0.020 |
Why?
| | Indoles | 1 | 1994 | 507 | 0.020 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1992 | 237 | 0.020 |
Why?
| | Edetic Acid | 1 | 1990 | 47 | 0.020 |
Why?
| | Arteries | 2 | 1988 | 261 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2000 | 1791 | 0.020 |
Why?
| | Guinea Pigs | 1 | 1990 | 159 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 1990 | 154 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1990 | 120 | 0.020 |
Why?
| | Body Weight | 1 | 1994 | 972 | 0.020 |
Why?
| | Enzyme Stability | 2 | 2005 | 73 | 0.020 |
Why?
| | Methionine | 1 | 1990 | 161 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1992 | 1300 | 0.020 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2014 | 376 | 0.020 |
Why?
| | Catalysis | 1 | 1990 | 305 | 0.020 |
Why?
| | Heart Arrest, Induced | 1 | 1989 | 26 | 0.020 |
Why?
| | Cell Survival | 2 | 1990 | 1103 | 0.020 |
Why?
| | Carmustine | 1 | 1988 | 52 | 0.020 |
Why?
| | Epithelium | 1 | 1990 | 311 | 0.020 |
Why?
| | Pentose Phosphate Pathway | 1 | 1988 | 55 | 0.020 |
Why?
| | Streptococcus pneumoniae | 2 | 1981 | 186 | 0.020 |
Why?
| | Biological Assay | 2 | 1981 | 132 | 0.020 |
Why?
| | Campylobacter fetus | 1 | 1988 | 1 | 0.020 |
Why?
| | Protamines | 1 | 1988 | 8 | 0.020 |
Why?
| | Temperature | 2 | 1983 | 633 | 0.020 |
Why?
| | Interleukin-2 | 1 | 1989 | 440 | 0.020 |
Why?
| | Campylobacter Infections | 1 | 1988 | 18 | 0.020 |
Why?
| | Papaverine | 1 | 1987 | 2 | 0.020 |
Why?
| | Prognosis | 1 | 1997 | 4329 | 0.020 |
Why?
| | Organ Specificity | 1 | 1988 | 309 | 0.020 |
Why?
| | Helium | 1 | 2007 | 6 | 0.020 |
Why?
| | Antimycin A | 2 | 1995 | 14 | 0.020 |
Why?
| | Microbial Collagenase | 1 | 1987 | 8 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1996 | 962 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2007 | 37 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 42 | 0.020 |
Why?
| | Constriction | 1 | 1987 | 45 | 0.020 |
Why?
| | Hemiplegia | 1 | 1987 | 20 | 0.020 |
Why?
| | Nicotine | 1 | 1990 | 331 | 0.020 |
Why?
| | Membranes | 1 | 1987 | 13 | 0.020 |
Why?
| | Heart Ventricles | 2 | 1989 | 756 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 331 | 0.020 |
Why?
| | Complement C3 | 1 | 1988 | 187 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 1986 | 5428 | 0.020 |
Why?
| | Fatty Acids | 3 | 1975 | 457 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 144 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2007 | 159 | 0.020 |
Why?
| | Cell Membrane | 3 | 1978 | 709 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1988 | 514 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1990 | 359 | 0.010 |
Why?
| | Carboxypeptidases | 1 | 1985 | 12 | 0.010 |
Why?
| | Drug Synergism | 1 | 1986 | 354 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1987 | 208 | 0.010 |
Why?
| | Surface Properties | 1 | 2007 | 386 | 0.010 |
Why?
| | Tissue Adhesions | 1 | 1985 | 34 | 0.010 |
Why?
| | Sneezing | 1 | 1985 | 1 | 0.010 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2005 | 112 | 0.010 |
Why?
| | Lipid Peroxides | 1 | 1985 | 10 | 0.010 |
Why?
| | Granuloma | 1 | 1985 | 97 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1184 | 0.010 |
Why?
| | Sheep | 2 | 1988 | 876 | 0.010 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1985 | 35 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1987 | 500 | 0.010 |
Why?
| | Cell Communication | 1 | 1987 | 327 | 0.010 |
Why?
| | Rheology | 1 | 1985 | 94 | 0.010 |
Why?
| | Hemodynamics | 4 | 1991 | 1118 | 0.010 |
Why?
| | Bacteria | 2 | 1981 | 766 | 0.010 |
Why?
| | Mucous Membrane | 1 | 1985 | 128 | 0.010 |
Why?
| | Pleurisy | 1 | 1983 | 6 | 0.010 |
Why?
| | Cyanamide | 1 | 1983 | 1 | 0.010 |
Why?
| | Singlet Oxygen | 1 | 1984 | 18 | 0.010 |
Why?
| | Cough | 1 | 1985 | 124 | 0.010 |
Why?
| | Radiation Injuries, Experimental | 1 | 1983 | 20 | 0.010 |
Why?
| | Behavior, Animal | 1 | 1987 | 520 | 0.010 |
Why?
| | Respiratory System | 1 | 1985 | 150 | 0.010 |
Why?
| | Dietary Proteins | 1 | 1985 | 135 | 0.010 |
Why?
| | Blood Glucose | 4 | 1983 | 2344 | 0.010 |
Why?
| | Immunization | 1 | 1985 | 375 | 0.010 |
Why?
| | Molecular Weight | 1 | 1983 | 312 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1723 | 0.010 |
Why?
| | Prostanoic Acids | 1 | 1983 | 1 | 0.010 |
Why?
| | BCG Vaccine | 1 | 1983 | 27 | 0.010 |
Why?
| | Mammals | 1 | 1985 | 286 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1985 | 274 | 0.010 |
Why?
| | Macrophage Activation | 1 | 1984 | 181 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1986 | 318 | 0.010 |
Why?
| | Mice, Inbred BALB C | 2 | 1996 | 1261 | 0.010 |
Why?
| | Dietary Fats | 1 | 1985 | 308 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 2005 | 297 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1982 | 12 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1982 | 27 | 0.010 |
Why?
| | Pulmonary Fibrosis | 1 | 1986 | 395 | 0.010 |
Why?
| | Serum Albumin, Bovine | 1 | 1982 | 62 | 0.010 |
Why?
| | Stimulation, Chemical | 2 | 1978 | 52 | 0.010 |
Why?
| | Leukocyte Adherence Inhibition Test | 1 | 1981 | 1 | 0.010 |
Why?
| | Imidazoles | 1 | 1983 | 247 | 0.010 |
Why?
| | Histoplasmosis | 1 | 1981 | 15 | 0.010 |
Why?
| | Pulmonary Veins | 1 | 1982 | 108 | 0.010 |
Why?
| | Vacuoles | 2 | 1978 | 38 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 1981 | 63 | 0.010 |
Why?
| | Skin Tests | 1 | 1981 | 94 | 0.010 |
Why?
| | Enterococcus faecalis | 2 | 1979 | 29 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2005 | 1115 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1983 | 452 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1981 | 224 | 0.010 |
Why?
| | Ethane | 1 | 1979 | 2 | 0.010 |
Why?
| | Keto Acids | 1 | 1979 | 10 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 1983 | 478 | 0.010 |
Why?
| | Hexosephosphates | 1 | 1979 | 2 | 0.010 |
Why?
| | Bacteriolysis | 1 | 1979 | 10 | 0.010 |
Why?
| | Ferrous Compounds | 1 | 1979 | 25 | 0.010 |
Why?
| | Peroxides | 1 | 1979 | 17 | 0.010 |
Why?
| | Chemistry | 1 | 1979 | 41 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1979 | 16 | 0.010 |
Why?
| | Electromagnetic Phenomena | 1 | 1979 | 24 | 0.010 |
Why?
| | Anesthesia, Local | 1 | 1979 | 26 | 0.010 |
Why?
| | Butyrates | 1 | 1979 | 66 | 0.010 |
Why?
| | Aldehydes | 1 | 1979 | 140 | 0.010 |
Why?
| | Blastomyces | 1 | 1978 | 9 | 0.010 |
Why?
| | Immune Sera | 1 | 1978 | 77 | 0.010 |
Why?
| | Heterozygote | 1 | 1979 | 314 | 0.010 |
Why?
| | Immunoglobulins | 1 | 1978 | 163 | 0.010 |
Why?
| | Bronchoscopy | 1 | 1979 | 227 | 0.010 |
Why?
| | Species Specificity | 1 | 1978 | 546 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1982 | 1512 | 0.010 |
Why?
| | Hypergammaglobulinemia | 1 | 1976 | 8 | 0.010 |
Why?
| | Phenylbutazone | 1 | 1976 | 4 | 0.010 |
Why?
| | Glycolysis | 1 | 1978 | 340 | 0.010 |
Why?
| | Leucine Zippers | 1 | 1996 | 13 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1996 | 48 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 37 | 0.010 |
Why?
| | Eczema | 1 | 1976 | 66 | 0.010 |
Why?
| | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1995 | 5 | 0.010 |
Why?
| | Syndrome | 1 | 1976 | 381 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1975 | 68 | 0.010 |
Why?
| | Platelet Aggregation | 1 | 1975 | 99 | 0.010 |
Why?
| | Mitochondria, Liver | 1 | 1995 | 70 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1975 | 100 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1995 | 78 | 0.010 |
Why?
| | Protons | 1 | 1995 | 96 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 1976 | 315 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1995 | 143 | 0.010 |
Why?
| | Carbon Radioisotopes | 1 | 1974 | 29 | 0.010 |
Why?
| | Inclusion Bodies | 1 | 1974 | 27 | 0.010 |
Why?
| | Coloring Agents | 1 | 1974 | 89 | 0.010 |
Why?
| | Staphylococcus | 1 | 1974 | 74 | 0.010 |
Why?
| | Spleen | 1 | 1996 | 508 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1994 | 268 | 0.010 |
Why?
| | Vascular Diseases | 1 | 1975 | 252 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1978 | 968 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 87 | 0.010 |
Why?
| | Solutions | 1 | 1991 | 159 | 0.010 |
Why?
| | Blood | 1 | 1991 | 107 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1996 | 740 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 153 | 0.010 |
Why?
| | Nitroglycerin | 1 | 1990 | 14 | 0.000 |
Why?
| | Cold Temperature | 1 | 1991 | 206 | 0.000 |
Why?
| | Insulin | 1 | 1980 | 2516 | 0.000 |
Why?
| | Half-Life | 1 | 1989 | 155 | 0.000 |
Why?
| | Blood Gas Analysis | 1 | 1989 | 82 | 0.000 |
Why?
| | DNA-Binding Proteins | 1 | 1996 | 1482 | 0.000 |
Why?
| | Microspheres | 1 | 1989 | 142 | 0.000 |
Why?
| | Complement C9 | 1 | 1988 | 5 | 0.000 |
Why?
| | Child | 2 | 1979 | 22739 | 0.000 |
Why?
| | Fluoresceins | 1 | 1988 | 48 | 0.000 |
Why?
| | Complement C5 | 1 | 1988 | 33 | 0.000 |
Why?
| | Thiocyanates | 1 | 1988 | 28 | 0.000 |
Why?
| | Coronary Vessels | 1 | 1990 | 246 | 0.000 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 1988 | 36 | 0.000 |
Why?
| | Quinidine | 1 | 1987 | 5 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 6 | 0.000 |
Why?
| | Phenotype | 1 | 1976 | 3170 | 0.000 |
Why?
| | Virulence | 1 | 1988 | 278 | 0.000 |
Why?
| | Heparin | 1 | 1988 | 247 | 0.000 |
Why?
| | Fluorescent Dyes | 1 | 1988 | 334 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1976 | 1925 | 0.000 |
Why?
| | Swine | 1 | 1988 | 826 | 0.000 |
Why?
| | Aorta, Thoracic | 1 | 1988 | 286 | 0.000 |
Why?
| | Stroke Volume | 1 | 1988 | 655 | 0.000 |
Why?
| | Pleura | 1 | 1983 | 28 | 0.000 |
Why?
| | Cytochalasin B | 1 | 1982 | 8 | 0.000 |
Why?
| | Micropore Filters | 1 | 1982 | 4 | 0.000 |
Why?
| | Transducers, Pressure | 1 | 1982 | 12 | 0.000 |
Why?
| | Ultrafiltration | 1 | 1982 | 28 | 0.000 |
Why?
| | Polysaccharides, Bacterial | 1 | 1981 | 69 | 0.000 |
Why?
| | Tritium | 1 | 1980 | 67 | 0.000 |
Why?
| | Cytoplasmic Granules | 1 | 1979 | 60 | 0.000 |
Why?
| | Microvilli | 1 | 1978 | 75 | 0.000 |
Why?
| | Myristates | 1 | 1977 | 1 | 0.000 |
Why?
| | Histocompatibility Testing | 1 | 1975 | 123 | 0.000 |
Why?
|
|
Repine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|